Abstract
This study aimed to investigate the antidiabetic and antihyperlipidemic activity of the active fraction of Asparagus gonoclados root tubers (AGAF) in streptozotocin-induced diabetic rats. After 45 days of treatment with the active fraction (AGAF) of Asparagus gonoclados at a dose of 50 mg/kg b.w.t., the levels of fasting blood glucose (FBG), hemoglobin, HbA1c, insulin, serum lipid profiles, and renal and hepatic function markers were measured in all experimental groups of rats. Treatment with AGAF remarkably normalized the FBG, insulin, and lipid profile levels. AGAF also normalized the hepatic and renal function markers in STZ-induced diabetic-treated rats. The findings from our current study confirm that AGAF successfully alleviates diabetes mellitus and its associated complications by improving insulin secretion and action with no apparent toxic effects on the liver or kidney.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Biologically Active Products from Nature
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
